Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Mahip Grewal

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1714-226X; OpenAlex author ID A5102647985. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2024: 4 papers · 2025: 5 papers

Papers 9

  1. Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer Database. Co-author DOI 10.1002/wjs.12431↗
  2. Risk of pancreatic cancer and high-grade dysplasia in resected main-duct and mixed-type intraductal papillary mucinous neoplasms: A prevalence meta-analysis. Co-author DOI 10.1016/j.ejso.2025.109742↗
  3. Reply to: Comment on "Risk of pancreatic cancer and high-grade dysplasia in resected main-duct and mixed-type intraductal papillary mucinous neoplasms: A preva… Co-author DOI 10.1016/j.ejso.2025.110111↗
  4. Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysis. Co-author DOI 10.1093/jnci/djae294↗
  5. Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer: A M… Co-author DOI 10.1097/sla.0000000000006295↗
  6. Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancer. Co-author DOI 10.1111/jgh.16686↗
  7. Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study. Co-author DOI 10.1200/jco.23.02313↗
  8. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Co-author DOI 10.1245/s10434-024-15281-1↗
  9. ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15391-w↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ammar A. Javed · 9 shared papers, 2024–2025 · strength 2.04
  2. Christopher L. Wolfgang · 7 shared papers, 2024–2025 · strength 1.46
  3. Omar Mahmud · 5 shared papers, 2024–2025 · strength 1.30
  4. Marc G. Besselink · 6 shared papers, 2024–2025 · strength 1.22
  5. Greg D. Sacks · 4 shared papers, 2024–2025 · strength 0.99
  6. Lois A. Daamen · 4 shared papers, 2024–2025 · strength 0.77
  7. Daniel Brock Hewitt · 3 shared papers, 2024–2025 · strength 0.66
  8. Jin Peng He · 3 shared papers, 2024–2025 · strength 0.59
  9. Izaak Quintus Molenaar · 3 shared papers, 2024–2025 · strength 0.52
  10. Joseph R. Habib · 3 shared papers, 2024–2025 · strength 0.52
  11. Sarah R. Kaslow · 2 shared papers, 2025 · strength 0.43
  12. Ingmar Florin Rompen · 2 shared papers, 2024–2025 · strength 0.39
  13. Paul C. M. Andel · 2 shared papers, 2024–2025 · strength 0.39
  14. Hjalmar C. van Santvoort · 2 shared papers, 2024–2025 · strength 0.39
  15. Markus Wolfgang Büchler · 2 shared papers, 2024 · strength 0.31
  16. Martin Loos · 2 shared papers, 2024 · strength 0.31
  17. Benedict Kinny‐Köster · 2 shared papers, 2024 · strength 0.31
  18. Nabiha Akhlaq Mughal · 1 shared paper, 2025 · strength 0.25
  19. Christopher Lee Wolfgang · 1 shared paper, 2025 · strength 0.25
  20. Anthony M Sorrentino · 1 shared paper, 2025 · strength 0.22
  21. Megan D. Winner · 1 shared paper, 2025 · strength 0.22
  22. Diane M. Simeone · 1 shared paper, 2025 · strength 0.22
  23. John Allendorf · 1 shared paper, 2025 · strength 0.22
  24. Jing He · 1 shared paper, 2024 · strength 0.18
  25. Matthew H. G. Katz · 1 shared paper, 2024 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.